drugset
drugset / Trial / NCT03898583

Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis.

NCT03898583 ↗

Phase 1 Completed 15 enrolled LEO Pharma
RandomizedCrossoverSingle-blindTreatment

Summary

To assess safety, tolerability and pharmacodynamics effect of treatment with microarray patches containing calcipotriol and betamethasone dipropionate.

Timeline

Start
2019-04-15
Primary completion
2019-10-29
Completion
2019-10-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcipotriol Small molecule — Other
Subject betamethasone dipropionate Small molecule — Other

Indications

psoriasis